ERG and prostate neoplasm: According to the type of single alteration (Table 2), single ERG positive immunostaining was found in 30.8% of GS = 6, 14.6% of GS = 7 and in 15.4% of GS ≥ 8 prostate tumor samples (Pearson Chi-Square, p = 0.062).